Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Carcinoma, Basal Cell 2Tongue Neoplasms 1Sezary Syndrome 1Pancreatic Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoid Interstitial Pneumonia 1Keratosis, Actinic 1Basal Cell Nevus Syndrome 1

Interventions

Aminolevulinic Acid 183-ingenyl angelate 16Imiquimod 9Photochemotherapy 8methyl 5-aminolevulinate 7Solutions 5LEO 43204 4Gels 4BF-200 ALA 4Fluorouracil 3Cryotherapy 3tirbanibulin 2Ointments 2Blue Light 2tazarotene 1perillyl alcohol 1cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1bacitracin, polymyxin B drug combination 1Therapies, Investigational 1Petrolatum 1Lasers 1Laser Therapy 1Excipients 1Diclofenac 1Cholecalciferol 1Celecoxib 1Biafine 1Benzoyl Peroxide 1Bacitracin 15-aminolevulinic acid hexyl ester 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Keratosis, Actinic × 1-phenyl-3,3-dimethyltriazene × Clear all
NCT01966120 2023-07-28

Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)

Biofrontera Bioscience GmbH

Phase 3 Completed
87 enrolled 21 charts
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡